Dejia Huang
Sichuan University
QRS complexRisk assessmentInternal medicineCardiologyIntensive care medicineMortality rateProspective cohort studyEmergency medicineClinical endpointHazard ratioSudden cardiac deathMulticenter trialCardiac resynchronization therapyVentricular tachycardiaImplantable cardioverter-defibrillatorLeft bundle branch blockDefibrillationSudden cardiac arrestReimbursementGuidelinePopulationProportional hazards modelClinical trialMedicineRelative risk reduction
Publications 6
#1Shu Zhang (Peking Union Medical College)H-Index: 69
Abstract Background Implantable cardioverter defibrillators (ICDs) are underutilized in Asia, Latin America, Eastern Europe, Middle East, and Africa. Improve SCA is the largest prospective study to evaluate the benefit of ICD therapy in under-represented geographies. This analysis reports the primary objective of the study. Objectives To determine whether primary prevention (PP) patients with specific risk factors (1.5PP: syncope, NSVT, PVCs>10/h, LVEF Methods A total of 3,889 patients were incl...
#3Shu ZhangH-Index: 69
#1Giuseppe Boriani (University of Modena and Reggio Emilia)H-Index: 87
#2Laurent Fauchier (François Rabelais University)H-Index: 61
Last. Ashley Chin (UCT: University of Cape Town)H-Index: 11
view all 18 authors...
European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS).
BACKGROUND: Despite available evidence that implantable cardioverter defibrillators (ICDs) reduce all-cause mortality among patients at risk for sudden cardiac death, utilization of ICDs is low especially in developing countries. OBJECTIVE: To summarize reasons for ICD or cardiac resynchronization therapy defibrillator implant refusal by patients at risk for sudden cardiac arrest (Improve SCA) in developing countries. METHODS: Primary prevention (PP) and secondary prevention (SP) patients from c...
#1Shu Zhang (Peking Union Medical College)H-Index: 69
Aims This study aims to demonstrate that primary prevention (PP) patients with one or more additional risk factors are at a similar risk of life-threatening ventricular arrhythmias when compared with secondary prevention (SP) patients, and would receive similar benefit from an implantable cardioverter defibrillator (ICD), or cardiac resynchronization therapy-defibrillator (CRT-D) implant. The study evaluates the benefits of therapy for high-risk patients in countries where defibrillation therapy...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.